Literature DB >> 27632900

α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function.

Wei-Li Kuan1, Neal Bennett2, Xiaoling He3, Jeremy N Skepper4, Nataly Martynyuk3, Ruwani Wijeyekoon3, Prabhas V Moghe5, Caroline H Williams-Gray3, Roger A Barker6.   

Abstract

Recently it has been shown that there is impaired cerebral endothelial function in many chronic neurodegenerative disorders including Alzheimer's and Huntington's disease. Such problems have also been reported in Parkinson's disease, in which α-synuclein aggregation is the pathological hallmark. However, little is known about the relationship between misfolded α-synuclein and endothelial function. In the present study, we therefore examined whether α-synuclein preformed fibrils affect endothelial function in vitro. Using a well-established endothelial cell model, we found that the expression of tight junction proteins, in particular zona occludens-1 and occludin, was significantly perturbed in the presence of fibril-seeded neurotoxicity. Disrupted expression of these proteins was also found in the postmortem brains of patients dying with Parkinson's disease. There was though little evidence in vitro of functional impairments in endothelial cell function in terms of transendothelial electrical resistance and permeability. This study therefore shows for the first time that misfolded α-synuclein can interact and affect the cerebral endothelial system, although its relevance to the pathogenesis of Parkinson's disease remains to be elucidated.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Blood-brain barrier; Occludin; Parkinson's disease; Permeability; Transendothelial electrical resistance; Zona occludens-1; α-Synuclein preformed fibrils

Mesh:

Substances:

Year:  2016        PMID: 27632900     DOI: 10.1016/j.expneurol.2016.09.003

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  16 in total

Review 1.  Is Gut Dysbiosis an Epicenter of Parkinson's Disease?

Authors:  Charul Rajput; Alika Sarkar; Nidhi Sachan; Neeraj Rawat; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2021-01-05       Impact factor: 3.996

2.  Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson's disease.

Authors:  Dan-Hao Xia; Han Liu; Hai-Yan Tian; Xue-Bing Ding; Xin-Xin Wang; Yu Fu; Yong-Kang Chen; Chi Qin; Jiu-Qi Wang; Zhi Xiang; Zhong-Xian Zhang; Qin-Chen Cao; Wei Wang; Jia-Yi Li; Erxi Wu; Bei-Sha Tang; Ming-Ming Ma; Jun-Fang Teng; Xue-Jing Wang
Journal:  Nat Med       Date:  2021-01-18       Impact factor: 53.440

3.  The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.

Authors:  Nolwen L Rey; Daniel W Wesson; Patrik Brundin
Journal:  Neurobiol Dis       Date:  2016-12-20       Impact factor: 5.996

Review 4.  Modeling Neurovascular Disorders and Therapeutic Outcomes with Human-Induced Pluripotent Stem Cells.

Authors:  Allison M Bosworth; Shannon L Faley; Leon M Bellan; Ethan S Lippmann
Journal:  Front Bioeng Biotechnol       Date:  2018-01-30

Review 5.  The Blood-Brain Barrier and Its Intercellular Junctions in Age-Related Brain Disorders.

Authors:  Laura Costea; Ádám Mészáros; Hannelore Bauer; Hans-Christian Bauer; Andreas Traweger; Imola Wilhelm; Attila E Farkas; István A Krizbai
Journal:  Int J Mol Sci       Date:  2019-11-03       Impact factor: 5.923

Review 6.  Overview of Crosstalk Between Multiple Factor of Transcytosis in Blood Brain Barrier.

Authors:  Marco Tjakra; Yeqi Wang; Vicki Vania; Zhengjun Hou; Colm Durkan; Nan Wang; Guixue Wang
Journal:  Front Neurosci       Date:  2020-01-21       Impact factor: 4.677

7.  Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson's Disease.

Authors:  Irene García-Domínguez; Karolina Veselá; Juan García-Revilla; Alejandro Carrillo-Jiménez; María Angustias Roca-Ceballos; Marti Santiago; Rocío M de Pablos; José L Venero
Journal:  Front Cell Neurosci       Date:  2018-11-06       Impact factor: 5.505

8.  The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge.

Authors:  Sven C D van IJzendoorn; Pascal Derkinderen
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.568

9.  Brain Endothelial P-Glycoprotein Level Is Reduced in Parkinson's Disease via a Vitamin D Receptor-Dependent Pathway.

Authors:  Hyojung Kim; Jeong-Yong Shin; Yun-Song Lee; Seung Pil Yun; Han-Joo Maeng; Yunjong Lee
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

10.  Systemic α-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson's disease.

Authors:  Wei-Li Kuan; Katherine Stott; Xiaoling He; Tobias C Wood; Sujeong Yang; Jessica C F Kwok; Katie Hall; Yanyan Zhao; Ole Tietz; Franklin I Aigbirhio; Anthony C Vernon; Roger A Barker
Journal:  Mol Psychiatry       Date:  2019-11-22       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.